Eli Lilly and Company and Nexus Pharmaceuticals News and Resources

Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC have announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a leading sterile manufacturer in the pharmaceutical industry. This acquisition, announced on April 22, 2024, will take